Skip to main content

ÍS
EN

Forsíða

Forsíða

Sæmundur Rögnvaldsson - Postdoc

Sæmundur Rögnvaldsson

–

Heilbrigðisvísindasvið

Sæmundur Rögnvaldsson

Postdoc

Email
srognvald [at] hi.is

Unit
Research Faculty of Medicine

Published works

2024

Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceAnnals of Internal Medicine

2023

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategiesBlood Cancer Journal
Validity of chronic disease diagnoses in Icelandic healthcare registriesScandinavian Journal of Public Health
The force awakens, but questions remain: The future of MGUSBritish Journal of Haematology
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality indexBlood Cancer Journal

2022

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM studyBlood Cancer Journal

2021

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort studyBlood Cancer Journal
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategiesBlood Cancer Journal
Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population‐based cohort studyEuropean Journal of Haematology

Keywords for Specialisation:

Multiple myeloma

Hematological cancers

Internal medicine